Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Chemomab Therapeutics Ltd. (ANCN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 20,572 options to buy
@ $1.7, valued at
$35k
Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 10,123 options to buy
@ $0.8, valued at
$8.1k
|
|
| 06/16/2023 |
4
| Fatal Sigal (CFO) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 102,860 options to buy
@ $1.7, valued at
$174.9k
Granted 29,400 options to buy
@ $2.11, valued at
$62k
Granted 35,600 options to buy
@ $9.83, valued at
$349.9k
|
|
| 03/23/2023 |
4
| Moses Alan Charles (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/23/2023 |
4
| Nicaise Claude (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/23/2023 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,875 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 688 options to buy
@ $13.17, valued at
$9.1k
|
|
| 03/23/2023 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,857 options to buy
@ $1.62, valued at
$11.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 10,123 options to buy
@ $0.8, valued at
$8.1k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Marvin Donald (Executive VP, CFO & COO) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 250 shares
@ $3.3, valued at
$825
Bought 250 shares
@ $3.25, valued at
$812.5
Granted 196,875 options to buy
@ $9.77, valued at
$1.9M
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 2,000 shares
@ $3.19, valued at
$6.4k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 688 options to buy
@ $13.17, valued at
$9.1k
|
|
| 03/21/2022 |
4
| Maryles Joel Michael (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 500 shares
@ $4.32, valued at
$2.2k
Bought 500 shares
@ $4.36, valued at
$2.2k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/21/2022 |
4
| Marvin Donald (Executive VP, CFO & COO) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 250 shares
@ $4, valued at
$1k
Bought 250 shares
@ $3.98, valued at
$995
Bought 250 shares
@ $3.9, valued at
$975
Bought 250 shares
@ $4.1, valued at
$1k
Bought 250 shares
@ $4.2, valued at
$1.1k
Granted 196,875 options to buy
@ $9.77, valued at
$1.9M
|
|
| 03/15/2022 |
4
| Pfost Dale R (CEO) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 1,800 shares
@ $3.98, valued at
$7.2k
Bought 700 shares
@ $3.97, valued at
$2.8k
Granted 459,353 options to buy
@ $10.05, valued at
$4.6M
|
|
| 03/15/2022 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 2,000 shares
@ $4.2, valued at
$8.4k
Bought 2,000 shares
@ $4.3, valued at
$8.6k
Bought 2,000 shares
@ $4.56, valued at
$9.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 688 options to buy
@ $13.17, valued at
$9.1k
|
|
| 03/14/2022 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 1,200 shares
@ $4.28, valued at
$5.1k
Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
Granted 10,123 options to buy
@ $0.8, valued at
$8.1k
|
|
| 03/09/2022 |
4
| Darvish Nissim (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/09/2022 |
4
| Nicaise Claude (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/09/2022 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
|
|
| 03/09/2022 |
4
| Moses Alan Charles (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/09/2022 |
4
| Maryles Joel Michael (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 6,820 options to buy
@ $3.53, valued at
$24.1k
Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 12/08/2021 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 2,000 shares
@ $7.43, valued at
$14.9k
|
|
| 05/10/2021 |
4
| Fatal Sigal (CFO) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 35,653 options to buy
@ $27.26, valued at
$971.9k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Nicaise Claude (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 04/21/2021 |
4
| Moses Alan Charles (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 04/21/2021 |
4
| Maryles Joel Michael (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 11,884 options to buy
@ $27.26, valued at
$324k
|
|
| 03/26/2021 |
4
| Cohen Neil Harris (Director) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Bought 2,409 shares
@ $41.51, valued at
$100k
Bought 688 options to buy
@ $13.17, valued at
$9.1k
|
|
| 03/18/2021 |
4
| OrbiMed Israel GP Ltd. (10% Owner) has filed a Form 4 on Chemomab Therapeutics Ltd.|
Txns:
| Granted 288,170 shares
@ $17.35, valued at
$5M
Granted 28,817 warrants
@ $17.35, valued at
$500k
|
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|